Relationship between squamous cell carcinoma antigen levels and tumor volumes in patients with cervical carcinomas undergoing neoadjuvant chemotherapy

Gynecologic Oncology

Volumn 63, Issue 1, 1996, Pages 105-113

  Kim, Byoung Gie ^a   Kim, Jong Hoon ^a   Park, Sang Yoon ^a   Lee, Je Ho ^a   Lee, Eui Don ^a   Lee, Kyung Hee ^a   Park, Kee Bock ^a   Lee, Byung Hee ^a   Kim, Kie Hwan ^a  

^a Korea Cancer Center Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MITOMYCIN C; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ARTICLE; BLOOD LEVEL; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR VOLUME; UTERINE CERVIX CARCINOMA;

EID: 0030271905     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0287     Document Type: Article

References (24)

1. Ikteda, I. Two-site radioimmunometric (sandwich) assay of SCC antigen using monoclonal antibodies, in Squamous cell carcinoma antigen in the management of squamous cell carcinoma (H. Kato, H. W. A. de Bruijin, W. Evert, R. B. Herberman, and J. T. Johnson, Eds.), Excerpta Medica, Princeton, NJ pp. 215-226 (1987).
2. Kato, H., Morioka, H., Tsutsui, H., Aramaki, S., and Torigoe, T. Value of tumor-antigen (TA-4) of squamous cell carcinoma in predicting the extent of cervical cancer, Cancer 50, 1294- 1296 (1982).
3. Kato, H., Morioka, H., Aramaki, S., Tamai, K., and Torigoe, T. Prognostic significance of the tumor antigen TA-4 in squamous cell carcinoma of the uterine cervix, Am. J. Obstet. Gynecol. 145, 350-354 (1983).
4. Kato, H., Tamai, K., Morioka, H., Nagai, M., Nagaya, T., and Torigoe, T. Tumor-antigen TA-4 in the detection of recurrence in cervical squamous cell carcinoma, Cancer 54, 1544-1546 (1984).
5. Maruo, T., Shibata, K., Kimura, A., Hoshina, M., and Mochizuki, M. Tumor-associated antigen, TA-4, in the monitoring of the effects of therapy for squamous cell carcinoma of the uterine cervix, Cancer 56, 302-308 (1985).
6. Ngan, H., Cheng, G., Yeung, W., Wong, Y., and Ma, H. The prognostic value of TPA and SCC in squamous cell carcinoma of the cervix, Gynecol. Oncol. 52, 63-68 (1994).
7. Duk, J., Bruun, H., Groenier, K., Hollema, H., Hoor, K., Krans, M., and Aalders, J. Cancer of the uterine cervix: Sensitivity and specificity of serum squamous cell carcinoma antigen determination, Gynecol. Oncol. 39, 186-194 (1990).
8. Battaglia, F., Scambia, G., Panici, B., Castelli, M., Ferrandina, G., Foti, E., Amoroso, M., D'Andrea, G., and Mancuso, S. Immunosuppressive acidic protein (IAP) and squamous cell carcinoma antigen in patients with cervical cancer, Gynecol. Oncol. 53, 176-182 (1994).
9. Scambia, G., Panici, P. B., Foti, E., Amoroso, M., Salerno, G., Ferrandina, G., Battaglia, F., Greggi, S., Gaetano, A. D., Puglia, G., and Mancuso, S. Squamous cell carcinoma antigen: Prognostic significance and role in the monitoring of neoadjuvant chemotherapy response in cervical cancer, J. Clin. Oncol. 12, 2309-2316 (1994).
10. Ngan, H.-Y.-S., Wong, L.-C., Chan, S.-Y.-W., and Ma, H.-K. Use of serum squamous cell carcinoma antigen assays in chemotherapy of cervical cancer, Gynecol. Oncol. 35, 259-262 (1989).
11. Burghardt, E., Hoffman, H. M. H., Ebner, F., Haas, J., Tamussino, K., and Justich, E. Magnetic resonance imaging in cervical cancer: A basis for objective classification, Gynecol. Oncol. 33, 61-67 (1989).
12. Kim, K. H., Lee, B. H., Do, Y. S., Chin, S. Y., Park, S. Y., Kim, B. G., and Jang, J. J. Stage lib cervical carcinoma: MR evaluation of effect of the intraarterial chemotherapy, Radiology 192, 1-5 (1994).
13. Park, S. Y., Kim, B. G., Kim, J. H., Lee, J. H., Lee, E. D., Lee, K. H., Park, K. B., Lee, B. H., Kim, K. H. Phase I/II study of neoadjuvant intraarterial chemotherapy with mitomycin-C, vincristine, and cisplatin in patients with stage lib bulky cervical carcinoma, Cancer 76, 814-823 (1995).
14. Ngan, H., Chan, S.-Y.-W., Wong, L.-C., Choy, D.-T.-K., and Ma, H.-K. Serum squamous cell carcinoma antigen in the monitoring of radiotherapy treatment response in carcinoma of the cervix, Gynecol. Oncol. 57, 260-263 (1990).
15. Scambia, G., Panici, B.-P., Baiocchi, G., Amoroso, M., Foti, E., Greggi, S., and Mancuso, S. The value of squamous cell carcinoma antigen in patients with locally advanced cervical cancer undergoing neoadjuvant chemotherapy, Am. J. Obstet. Gynecol. 164, 631-636 (1991).
16. Yazigi, R., Munoz, A., Richardson, B., and Risser, R. Correlation of squamous cell carcinoma antigen levels and treatment response in cervical cancer, Gynecol. Oncol. 41, 135-138 (1991).
17. Tomas, C., Risteli, J., Risteli, L., Vuori, J., and Kaupilla, A. Use of various epithelial tumor markers and a stromal marker in the assessment of cervical carcinoma, Obstet. Gynecol. 77, 566-572 (1991).
18. Bolli, J.-A., Doering, D., Bosscher, J., Day, T., Rao, c., Owens, K., Kelly, B., and Goldsmith, J. Squamous cell carcinoma antigen: Clinical utility in squamous cell carcinoma of the uterine cervix, Gynecol. Oncol. 55, 169-173 (1994).
19. Molina, R., Filella, X., Torres, M. D., Balesta, A. M., Mengual, P., Cases, A., Balaque, A. SCC antigen measured in malignant and non-malignant disease, Clin. Chem. 36, 251-254 (1990).
20. Crombach, G., Scharl, A., Vierbuchen, M., Wurz, H., and Filbry, E. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinoma of the uterine cervix, Cancer 63, 1337-1342 (1989).
21. Holloway, R., To, A., Moradi, M., Boots, L., Watson, N., and Shingleton, H. Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay, Obstet. Gynecol. 74, 944-949 (1989).
22. Meier, W., Eiermann, W., Stieber, P., Fathen-Moghadam, A., Schneider, A., and Hepp, H. Squamous cell carcinoma antigen and carcinoembryonic antigen levels as prognostic factors for the response of cervical carcinoma to chemotherapy, Gynecol. Oncol. 38, 6-11 (1990).
23. Leminen, A., Alftan, H., Stenman, U.-F., and Lehtovirta, P. Chemotherapy as initial treatment for cervical carcinoma: Clinical and tumor marker response, Acta Obstet. Gynecol. Scand. 71, 293-297 (1992).
24. Rose, P., Baker, S., Fournier, L., Neison, B., and Hunter, R. Serum squamous cell carcinoma antigen levels in invasive cervical cancer: Prediction of response and recurrence, Am. J. Obstet. Gynecol. 168, 942-946 (1993).